SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-130541
Filing Date
2023-05-01
Accepted
2023-05-01 16:31:03
Documents
18
Period of Report
2023-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d470724d8k.htm   iXBRL 8-K 33279
2 EX-10.1 d470724dex101.htm EX-10.1 91403
3 EX-10.2 d470724dex102.htm EX-10.2 25545
4 EX-10.3 d470724dex103.htm EX-10.3 48485
5 EX-10.4 d470724dex104.htm EX-10.4 97525
6 EX-10.5 d470724dex105.htm EX-10.5 54835
10 GRAPHIC g470724g77a30.jpg GRAPHIC 4580
  Complete submission text file 0001193125-23-130541.txt   576367

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pkbo-20230428.xsd EX-101.SCH 2499
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkbo-20230428_lab.xml EX-101.LAB 18730
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkbo-20230428_pre.xml EX-101.PRE 11676
12 EXTRACTED XBRL INSTANCE DOCUMENT d470724d8k_htm.xml XML 3616
Mailing Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303
Business Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303 (650) 549-9103
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 23874214
SIC: 2836 Biological Products, (No Diagnostic Substances)